Halozyme Therapeutics, Inc. - Common Stock (HALO)
Seasonality Analysis
Halozyme Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Halozyme Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | -1.12% | Weak | |
| February | 0.86% | Moderate | |
| March | 2.23% | Weak | |
| April | -0.82% | Weak | |
| May | -0.26% | Weak | |
| June | 4.43% | Moderate | |
| July | 2.74% | Weak | |
| August | 0.25% | Moderate | |
| September | 2.15% | Weak | |
| October WORST | -2.22% | Weak | |
| November | 5.82% | Strong | |
| December BEST | 13.92% | Weak |
Halozyme Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Halozyme Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Halozyme Therapeutics, Inc. - Common Stock Pattern Scanner
Halozyme Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Halozyme Therapeutics, Inc. - Common Stock (HALO) Seasonality
Halozyme Therapeutics, Inc. - Common Stock (HALO) has been analyzed using 23 years of historical data to identify seasonal patterns. Classified under Stocks, Halozyme Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Halozyme Therapeutics, Inc. - Common Stock is historically December, with an average return of 13.92% and a win rate of 50%. Conversely, October tends to be the weakest month, averaging -2.22% return.
Looking at the full calendar year, Halozyme Therapeutics, Inc. - Common Stock has an average annual return of 27.97% with an overall monthly win rate of 50.4%. Out of 12 months, 8 typically show positive average returns.
The seasonal pattern for Halozyme Therapeutics, Inc. - Common Stock has a consistency score of 38.6 (Poor), based on 23 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Halozyme Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Halozyme Therapeutics, Inc. - Common Stock (HALO)?
Historically, December has been the best month for Halozyme Therapeutics, Inc. - Common Stock, with an average return of 13.92% and a win rate of 50%. However, past performance does not guarantee future results.
What is the worst month for Halozyme Therapeutics, Inc. - Common Stock (HALO)?
Based on historical data, October has been the weakest month for Halozyme Therapeutics, Inc. - Common Stock, with an average return of -2.22%. This is a historical observation and does not guarantee future results.
How reliable is HALO seasonality data?
The seasonality analysis for Halozyme Therapeutics, Inc. - Common Stock is based on 23 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Halozyme Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Halozyme Therapeutics, Inc. - Common Stock (HALO) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.